3 Factor Indexing’s Pfizer PFE Stock Holding History

3 Factor Indexing’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$506	Sell	21 -328	-94%	-$8.58K	﹤0.01%	186
2026 Q1	$9.8K	Buy	+349	New	+$9.29K	0.01%	127

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

3 Factor Indexing's PFE Position: Q2 2026 in Review

3 Factor Indexing reduced its Pfizer (PFE) stake by 94% in Q2 2026, selling an estimated $8.58K and leaving 21 shares worth $506. The position accounts for ﹤0.01% of the portfolio, ranked #186.

3 Factor Indexing first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $9.8K in Q1 2026. 2,713 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

3 Factor Indexing held 21 shares of Pfizer worth $506 as of Q2 2026.
3 Factor Indexing sold 328 Pfizer shares in Q2 2026, an estimated $8.58K.
Pfizer made up ﹤0.01% of 3 Factor Indexing's portfolio in Q2 2026, its #186 holding.
3 Factor Indexing first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
3 Factor Indexing's Pfizer position peaked at $9.8K in Q1 2026.
2,713 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on 3 Factor Indexing's 13F filing for Q2 2026, filed 8 Jul 2026.